Cannabidiol attenuates epileptic phenotype and increases survival in a mouse model of developmental and epileptic encephalopathy type 1
Epilepsia · 2025-10 · 66 (10) · 4035-4052
DOI: 10.1111/epi.18522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 03.07.2025. Verfasst von Lucia Verrillo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetics and Biophysics "Adriano Buzzati-Traverso," National Research Council of Italy (CNR), Naples, Italy. Hauptthemen laut MEDLINE: Cannabidiol, Anticonvulsants, Spasms, Infantile, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GW Research UK (now part of Jazz Pharmaceuticals;, Telethon Foundation, and Next Generation EU.
Abstract (Originalsprache)
Objective
Developmental and epileptic encephalopathy type 1 (DEE1) is a rare drug‐resistant pediatric epilepsy caused by trinucleotide repeat expansions in the X‐linked ARX gene, leading to elongation of the first polyalanine tract. It presents with early onset tonic seizures or spasms, developmental and cognition delay, and high risk of premature mortality. We evaluated the therapeutic potential of highly purified cannabidiol (CBD) in Arx (GCG)7/Y mice, a genetic DEE1 model that replicates key features of the human condition.
Methods
Arx (GCG)7/Y mice received daily intraperitoneal CBD (100 mg/kg) for 7 days. The epileptic phenotype was evaluated via video monitoring and a scoring matrix. In Arx ‐DEE1 male cortex, real‐time polymerase chain reaction and Western blotting assessed CBD effects on proinflammatory and neuronal markers. Microglial morphology was analyzed by Iba1 immunostaining and Sholl analysis. In vitro patch‐clamp recordings tested CBD activity on Arx (GCG)7/Y cortical neurons.
Results
CBD reduced the severity and frequency of spontaneous recurrent seizures and significantly extended the lifespan of epileptic mice. In mutant symptomatic mice, CBD activated peroxisome Pparg expression and the concurrent desensitization/inactivation of TRPV1 channels. Additionally, CBD counteracted the dysregulated expression of the proinflammatory genes Ptgs2, Mmp9, Il12, Cd68, Ccl2, and Irf3, while also restoring normal microglial morphology. Further molecular analysis demonstrated that CBD effectively offsets normal alternative splicing for the presynaptic receptor genes Nrnx1 and Nrnx3 . Consistent with this, CBD rescued proper Nrnx1 splicing in mutant cortical neurons after K + ‐induced depolarization. Finally, we found that CBD reduced neuronal excitability by inducing hyperpolarization, raising the action potential threshold, and reducing the frequency and mean charge of inhibitory postsynaptic currents and the mean charge of excitatory postsynaptic currents. Significance These findings represent the first preclinical evidence of CBD efficacy in a murine model of genetic DEE1, identifying CBD‐sensitive downstream targets and paving the way to further exploration of CBD effects in this disease for future clinical consideration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genetics and Biophysics "Adriano Buzzati-Traverso," National Research Council of Italy (CNR), Naples, Italy.
- Institute of Biomolecular Chemistry, National Research Council of Italy, Pozzuoli, Naples, Italy.
- Istituto Neurologico Mediterraneo Pozzilli (Neuromed) - Scientific Institute for Research , Hospitalization and Healthcare (IRCCS), Pozzilli (Isernia), Italy.
- Department of Human Sciences Society and Health, University of Cassino and Southern Lazio, Cassino (Frosinone), Italy.
- Department of Translational Medicine, Child Neurology, and Psychiatry, University of Naples "Federico II", Naples, Italy.
- Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.
ORCID-Profile: Lucia Verrillo, Fabio Arturo Iannotti, Denise Drongitis, Katiuscia Martinello, Loredana Poeta, Adriano Barra, Gaetano Terrone, Sergio Fucile, Vincenzo Di Marzo, Maria Giuseppina Miano
Förderung
- GW Research UK (now part of Jazz Pharmaceuticals;
- Telethon Foundation
- and Next Generation EU
- Ministry of Health
- National Recovery and Resilience Plan, Project AnIMANDo
- Italian Ministry of University and Research
- Ministry of University and Research
- National Recovery and Resilience Plan, project MNESYS
Zitieren
APA
Verrillo, L., Iannotti, F. A., Drongitis, D., Martinello, K., Poeta, L., Barra, A., Terrone, G., Fucile, S., Di Marzo, V., & Miano, M. G. (2025). Cannabidiol attenuates epileptic phenotype and increases survival in a mouse model of developmental and epileptic encephalopathy type 1. Epilepsia, 66(10), 4035-4052. https://doi.org/10.1111/epi.18522
Vancouver
Verrillo L, Iannotti FA, Drongitis D, Martinello K, Poeta L, Barra A, et al. Cannabidiol attenuates epileptic phenotype and increases survival in a mouse model of developmental and epileptic encephalopathy type 1. Epilepsia. 2025;66(10):4035-4052. doi:10.1111/epi.18522
BibTeX
@article{Verrillo2025,
author = {Verrillo, Lucia and Iannotti, Fabio Arturo and Drongitis, Denise and Martinello, Katiuscia and Poeta, Loredana and Barra, Adriano and Terrone, Gaetano and Fucile, Sergio and Di Marzo, Vincenzo and Miano, Maria Giuseppina},
title = {Cannabidiol attenuates epileptic phenotype and increases survival in a mouse model of developmental and epileptic encephalopathy type 1},
journal = {Epilepsia},
year = {2025},
volume = {66},
number = {10},
pages = {4035--4052},
doi = {10.1111/epi.18522}
}
EUVIMED